Metabolix

Bemis Company is the largest flexible packaging company in the Americas and a major manufacturer of pressure sensitive materials used for labels, decoration and signage. The company uses material science and innovation to supply a global marketplace. With operations in 62 locations in 11 countries, Bemis is poised to serve the increasingly complex and growing needs of multinational food and consumer products customers. Established in 1858 in St. Louis as a manufacturer of seamless cotton bags for milled food products, Bemis has played an influential role in the packaging industry ever since its founding. Now a global supplier of flexible packaging and pressure sensitive label materials headquartered in Minneapolis, Minn., the company serves customers worldwide and produces packaging for products found in virtually every aisle of the grocery store. Its Shirley, N.C., office is one of many in the U.S.

Ralco Industries is a manufacturing company based in Woonsocket, RI, specializing in the production of industrial components and machinery. With a focus on precision engineering and quality control, Ralco Industries serves a diverse range of clients across various industries. Utilizing advanced technology and skilled workforce, Ralco Industries is committed to delivering reliable and efficient solutions to meet the unique needs of its customers. The company's dedication to innovation and customer satisfaction sets it apart in the competitive manufacturing landscape. Generated from their business information

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.